Please ensure Javascript is enabled for purposes of website accessibility

Poorest Americans Dealt Biggest Blow Under Senate Republican Tax Package

10 hours ago

Trump Vowed to Dismantle MS-13. His Deal With Bukele Threatens That Effort.

14 hours ago

Ukraine Voices Concern as US Halts Some Missile Shipments

14 hours ago

Poll: Most Americans Say National Divide, Political Violence Threaten Democracy

15 hours ago

Paramount Settles With Trump Over ‘60 Minutes’ Interview for $16 Million

15 hours ago

Republicans Tee up House Vote on Trump Bill, Outcome Uncertain

15 hours ago

What’s Next for Sean ‘Diddy’ Combs After His Sex Trafficking Trial?

15 hours ago

Dalai Lama Says He Will Be Reincarnated, Trust Will Identify Successor

15 hours ago
Experts Scramble, but New Virus Vaccine May Not Come in Time
gvw_ap_news
By Associated Press
Published 5 years ago on
February 7, 2020

Share

WASHINGTON — The flu-like virus that exploded from China has researchers worldwide once again scrambling to find a vaccine against a surprise health threat, with no guarantee one will arrive in time.
Just days after Chinese scientists shared the genetic map of the culprit coronavirus, researchers at the U.S. National Institutes of Health had engineered a possible key ingredient for a vaccine they hope to begin testing by April.
Scientists from Australia to France, along with a list of biotech and vaccine companies, jumped in the race, pursuing different types of inoculations.

“We have the technology now. It’s feasible from an engineering and biological standpoint.” Dr. Barney Graham, deputy director of the National Institute of Allergy and Infectious Diseases’ Vaccine Research Center
And Texas researchers froze an experimental vaccine developed too late to fight an earlier coronavirus — SARS, or severe acute respiratory syndrome — but are pushing U.S. and Chinese authorities to give it a try this time around. Because the new virus is a close cousin of SARS, it just might protect, said Dr. Peter Hotez of Baylor College of Medicine and Texas Children’s Hospital.
All that work is coming at lightning speed compared to past outbreaks. Yet many experts agree it still may take a year — if every step along the way goes well — for any vaccine to be ready for widespread use. That’s if it’s even needed by then.
Globally, more than 28,000 people are infected and the death toll climbed past 560. The overwhelming majority are in China, but more than 200 people with the illness have been reported in over two dozen other countries.
For now, health officials are isolating the sick to fight spread of the virus, which causes fever, cough and in severe cases pneumonia. With no specific treatment, some doctors also are experimenting with antiviral medicines developed for other conditions.
“Ours is already manufactured and could take off pretty quickly,” said Hotez, who created the earlier SARS vaccine with Texas Children’s colleague Maria Elena Bottazzi. But “there’s still no road map for what you do to make a vaccine in the midst of a devastating public health outbreak.”
NIH specialists say rather than chasing outbreaks, it’s time to pursue prototype vaccine designs that could work for entire virus families, ready to be pulled off the shelf at the first sign of a new disease.
“We have the technology now. It’s feasible from an engineering and biological standpoint,” said Dr. Barney Graham, deputy director of the National Institute of Allergy and Infectious Diseases’ Vaccine Research Center. Without that step, “we’re going to be at risk for new pandemics.”
Photo of Pasteur Institute in Paris
View of the logo at Pasteur Institute in Paris, Thursday, Feb. 6, 2020. Scientists at the Pasteur Institute developed and shared a quick test for the new virus that is spreading worldwide, and are using genetic information about the coronavirus to develop a potential vaccine and treatments. (AP Photo/Francois Mori)

A Faster Vaccine Recipe

Traditionally, making vaccines required first growing lots of virus in a lab. The NIH team is pursuing a newer and far faster method: Simply use a piece of the virus’ genetic code, called messenger RNA or mRNA, that instructs cells to make a particular protein.
“We think of RNA as the software of life,” said Dr. Tal Zaks, chief medical officer of Moderna Inc., which is developing mRNA vaccines for other diseases and working with NIH on the new coronavirus.
Inject the right piece and “you’ve taught the body to make its own medicine,” he explained. As cells produce just that protein, the immune system learns to recognize it, primed to attack if the entire virus ever comes along.
The target: A protein aptly named “spike” that lets the virus bind to cells. It studs the surface of coronaviruses — the new one as well as its cousins SARS, which erupted in China in 2002 and spread to 26 countries, and MERS, or Middle East respiratory syndrome, which emerged in 2012.
Graham’s team zeroed in on the RNA responsible for the new virus’ production of spike and then — because prior research showed the protein can change shape — engineered a more stable version of it.
Moderna is manufacturing samples of the synthetic mRNA vaccine for NIH to use in animal studies and, hopefully within three months, first-stage safety tests in people. If further testing proves it really works, the hope is scientists could simply swap in a new spike code if another coronavirus comes along.
That’s important because after three such outbreaks in less than 20 years, “this is not the last,” predicted Dr. Mark Denison, a virologist at Vanderbilt University Medical Center. It’s key to find vaccine “strategies that go after these unique things common to every coronavirus.”

What Else Is in the Pipeline

Inovio Pharmaceuticals is pursuing a similar approach with synthetic DNA, and recently reported promising results from first-stage testing of a MERS vaccine. It’s collaborating with a Chinese company, Beijing Advaccine, in hopes of being able to test a new vaccine candidate in China later this year.

“The work we’re doing now involves making a vaccine against measles but re-engineered in the sense that it has antigens from the new coronavirus.” virologist Frederic Tangy, head of Pasteur’s vaccine innovation department
In France, researchers at the Pasteur Institute are piggybacking on the tried-and-true vaccine against measles. They’ve had some early success mixing genetic material from other viruses into that vaccine, and now hope to put the immune system on alert against this new coronavirus in the same way.
“The work we’re doing now involves making a vaccine against measles but re-engineered in the sense that it has antigens from the new coronavirus,” said virologist Frederic Tangy, head of Pasteur’s vaccine innovation department.
What about Hotez’s old SARS vaccine? In that case a piece of the spike protein was genetically engineered and grown in a lab, a classic vaccine technology compared to the newer and less proven Moderna and Inovio approaches. The Texas researchers showed the vaccine protected animals but in 2016 ran out of money for further testing and froze what was left. Every six months, Hotez thaws a small sample to make sure it’s still usable.
Photo of a scientist holding samples
Vincent Enouf, Deputy director of National Flu Center displays samples prior to put them into machine for analyze at Pasteur Institute in Paris, Thursday, Feb. 6, 2020. Scientists at the Pasteur Institute developed and shared a quick test for the new virus that is spreading worldwide, and are using genetic information about the coronavirus to develop a potential vaccine and treatments. (AP Photo/Francois Mori)French lab scientist in hazmat gear inserting liquid in test tube

Chasing Outbreaks

Past outbreaks are full of such missed opportunities: There’s no commercial vaccine for MERS even though illnesses still occur. The birth defect-causing Zika outbreak was ending by the time experimental shots were ready to test.
The bright spot: Ebola vaccines. Some candidates began early testing during the massive Ebola epidemic in West Africa in 2014-2016, although the outbreak waned before scientists had proof they worked. But authorities and vaccine companies kept up the research, and by 2018 shots were ready to help tamp down an outbreak still smoldering in Congo.
The World Health Organization will meet next week to identify promising drug and vaccine candidates for the new coronavirus and fast-track their development, much like happened with Ebola.
“To put it bluntly, we’re shadow boxing,” said WHO Director-General Tedros Adhanom Ghebreyesus. “We need to bring this shadow out into the light so that we can attack it properly.”

DON'T MISS

What Are Fresno Real Estate Experts Predicting for 2025 and Beyond?

DON'T MISS

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

DON'T MISS

House Republicans Say They Expect to Vote Tonight on Trump’s Tax-Cut Bill

DON'T MISS

San Luis Obispo’s Madre Fire Grows to 8,300 Acres, Prompts Evacuations

DON'T MISS

SLO Deputies Fatally Shoot Man in Los Osos Weeks After US Marshal Impersonation Arrest

DON'T MISS

Madera County Deputy Injured, Wanted Felon Arrested After Violent Struggle

DON'T MISS

San Luis Obispo County Wildfire Burns More Than 3,000 Acres. No Containment Yet

DON'T MISS

Wired Wednesday: Why Is State Lawmaker Taking Aim at Rooftop Solar?

DON'T MISS

Two Visalia Men Sentenced in 2021 Motel Killing

DON'T MISS

Ex-Jan. 6 Defendant Gets Life in Prison for Plot to Kill FBI Agents

DON'T MISS

Del Monte Files for Bankruptcy. Gets Nearly $1B to Keep Producing Through Process

DON'T MISS

Who is Running for Fresno Area Offices in 2026? An Updated Look

UP NEXT

From Victims to Perpetrators: Israeli Soldiers’ Nazi Comparisons and the Unfolding War Crimes in Gaza

UP NEXT

Iran Enacts Law Suspending Cooperation With UN Nuclear Watchdog

UP NEXT

Ukraine Voices Concern as US Halts Some Missile Shipments

UP NEXT

Poll: Most Americans Say National Divide, Political Violence Threaten Democracy

UP NEXT

Dalai Lama Says He Will Be Reincarnated, Trust Will Identify Successor

UP NEXT

Hamas Says It Is Studying Ceasefire Proposal Labeled ‘Final’ by Trump

UP NEXT

Trump Pulls Back 150 Guard Troops From Federal Duties in California

UP NEXT

Trump Says Israel Has Agreed to Conditions to Finalize 60-Day Gaza Ceasefire

UP NEXT

Iran Made Preparations to Mine the Strait of Hormuz, US Sources Say

UP NEXT

Trump Says US Could Reach Trade Deal With India, Casts Doubt on Deal With Japan

Madera County Deputy Injured, Wanted Felon Arrested After Violent Struggle

8 hours ago

San Luis Obispo County Wildfire Burns More Than 3,000 Acres. No Containment Yet

8 hours ago

Wired Wednesday: Why Is State Lawmaker Taking Aim at Rooftop Solar?

8 hours ago

Two Visalia Men Sentenced in 2021 Motel Killing

9 hours ago

Ex-Jan. 6 Defendant Gets Life in Prison for Plot to Kill FBI Agents

9 hours ago

Del Monte Files for Bankruptcy. Gets Nearly $1B to Keep Producing Through Process

10 hours ago

Who is Running for Fresno Area Offices in 2026? An Updated Look

10 hours ago

CIA Review Finds Flaws but Does Not Dispute Finding Putin Sought to Sway 2016 Vote to Trump

10 hours ago

Poorest Americans Dealt Biggest Blow Under Senate Republican Tax Package

10 hours ago

Check Out Newest Downtown Mural. It’s a Spectacular Tribute to Fresno Artisans

11 hours ago

House Republicans Say They Expect to Vote Tonight on Trump’s Tax-Cut Bill

WASHINGTON – Republicans in the House of Representatives on Wednesday struggled to pass President Donald Trump’s massive tax-cut...

7 hours ago

Speaker of the House Mike Johnson speaks to the press, as Republican lawmakers struggle to pass U.S. President Donald Trump's sweeping spending and tax bill, on Capitol Hill, in Washington, D.C., U.S., July 2, 2025. (Reuters/Annabelle Gordon)
7 hours ago

House Republicans Say They Expect to Vote Tonight on Trump’s Tax-Cut Bill

The Madre Fire in San Luis Obispo County has rapidly expanded to 8,396 acres with no containment, prompting evacuation orders and warnings near New Cuyama. (CalFire)
7 hours ago

San Luis Obispo’s Madre Fire Grows to 8,300 Acres, Prompts Evacuations

Andrew Biscay, 40, was arrested Friday, June 20, 2025, after deputies found him with a fake U.S. Marshal’s badge, homemade firearm, and law enforcement-style gear during a warrant arrest. (Madera County SO)
7 hours ago

SLO Deputies Fatally Shoot Man in Los Osos Weeks After US Marshal Impersonation Arrest

On Tuesday, July 1, 2025, a Madera County sheriff’s deputy was injured while trying to arrest a wanted felon, Felix Adrian Nucamendi Carrasco, 40, who later fled and was captured near Raymond Road. (Madera County SO)
8 hours ago

Madera County Deputy Injured, Wanted Felon Arrested After Violent Struggle

A wildfire dubbed the Madre Fire has burned over 3,300 acres near New Cuyama with 0% containment, officials said Wednesday, July 2, 2025. (CalFire)
8 hours ago

San Luis Obispo County Wildfire Burns More Than 3,000 Acres. No Containment Yet

8 hours ago

Wired Wednesday: Why Is State Lawmaker Taking Aim at Rooftop Solar?

Jose Luna (left), 33, and Ralph Grajeda, 45, both of Visalia, have been sentenced for their roles in the 2020 shotgun killing of Robert Soto at a local motel. (Tulare County DA)
9 hours ago

Two Visalia Men Sentenced in 2021 Motel Killing

A U.S. Justice Department logo or seal showing Justice Department headquarters, known as "Main Justice," is seen behind the podium in the Department's headquarters briefing room before a news conference with the Attorney General in Washington, January 24, 2023. (Reuters File)
9 hours ago

Ex-Jan. 6 Defendant Gets Life in Prison for Plot to Kill FBI Agents

Help continue the work that gets you the news that matters most.

Search

Send this to a friend